Meloxicam
| Subclass of | non-steroidal anti-inflammatory drug, heterocyclic compound  |
|---|---|
| Get use | Medication |
| Chemical formula | C₁₄H₁₃N₃O₄S₂ |
| Canonical SMILES | CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O |
| Isomeric SMILES | CC1=CN=C(S1)/N=C(/C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O)\O |
| World Health Organisation international non-proprietary name | meloxicam |
| Medical condition treated | osteoarthritis, osteoarthritis susceptibility 1, arthritis, desmoid disease, hereditary |
| Physically dey interact plus | Prostaglandin-endoperoxide synthase 1, Prostaglandin-endoperoxide synthase 2 |
| Legal status (medicine) | boxed warning |
| Pregnancy category | Australian pregnancy category C, US pregnancy category C |
| Subject has role | cyclooxygenase inhibitors, non-steroidal anti-inflammatory drug |
Meloxicam, dem sell under de brand name Mobic among odas, be a nonsteroidal anti-inflammatory drug (NSAID) dem use to treat pain den inflammation insyd rheumatic diseases den osteoarthritis.[1][2] Dem dey take am by mouth anaa e be given by injection into a vein.[2][3] Dem dey recommend say e be used for as short a period as possible den at a low dose.[2]
Common side effects dey include abdominal pain, dizziness, swelling, headache, den a rash.[2] Serious side effects fi include heart disease, stroke, kidney problems, den stomach ulcers.[2] Ein use no be recommended insyd de third trimester of pregnancy.[2] E dey block cyclooxygenase-2 (COX-2) more dan e dey block cyclooxygenase-1 (COX-1).[2] E dey insyd de oxicam family of chemicals wey be closely related to piroxicam.[2]
E be available as a generic medication.[2] Insyd 2023, na e be de 27th most commonly prescribed medication insyd de United States, plus more dan 20 million prescriptions.[4][5] Na dem approve an intravenous version of meloxicam (Anjeso) for medical use insyd de United States insyd February 2020.[3][6] Meloxicam be available in combination plus bupivacaine as bupivacaine/meloxicam den in combination plus rizatriptan as meloxicam/rizatriptan.
References
[edit | edit source]- ↑ British national formulary: BNF 76 (76 ed.). Pharmaceutical Press. 2018. pp. 1112–1113. ISBN 978-0-85711-338-2.
- 1 2 3 4 5 6 7 8 9 "Meloxicam Monograph for Professionals". Drugs.com. AHFS. 10 June 2025. Retrieved 18 October 2025.
- 1 2 "Baudax Bio Announces FDA Approval of Anjeso for the Management of Moderate to Severe Pain". Baudax Bio, Inc. (Press release). 20 February 2020. Archived from the original on 21 February 2020. Retrieved 20 February 2020.
- ↑ "Top 300 of 2023". ClinCalc. Archived from the original on 12 August 2025. Retrieved 12 August 2025.
- ↑ "Meloxicam Drug Usage Statistics, United States, 2014 - 2023". ClinCalc. Retrieved 13 August 2025.
- ↑ "Anjeso- meloxicam injection". DailyMed. U.S. National Library of Medicine. 22 February 2022. Retrieved 8 October 2022.
External links
[edit | edit source]